Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Why India rejected a patent application for shorter drug-resistant TB treatment | Explained

The decision could open the door to greater generic competition, but its impact on treatment costs will depend on drug availability, pricing, and access to care

Why India rejected a patent application for shorter drug-resistant TB treatment | Explained

We haven't written up this one. The Hindu Health has the full story — the link below goes straight to it.

Read the original at thehindu.com →

More in Health & Medicine

How to Read an HIV Test Kit

Learning how to read an HIV test kit can help you understand your test results and know when to seek further testing. HIV self-test kits allow people to check for signs of HIV infection using a sample…

WHO Kenya Newsletter | October 2026

WHO Kenya Newsletter | October 2026 printg@who.int Thu, 29/10/2026 - 09:02 Join us for our July to October 2026 newsletter as Kenya acts swiftly on its first cases of Bundibugyo Ebola, all 47 counties…

More from Thursday 29 October →